Research analysts at Credit Suisse Group AG began coverage on shares of LifePoint Health, Inc. (NASDAQ:LPNT) in a report issued on Thursday. The brokerage set a “neutral” rating and a $54.00 price target on the stock. Credit Suisse Group AG’s target price points to a potential upside of 12.15% from the stock’s previous close.

Several other brokerages also recently issued reports on LPNT. Royal Bank Of Canada reissued a “buy” rating and issued a $77.00 price target on shares of LifePoint Health in a report on Wednesday, July 5th. BidaskClub downgraded LifePoint Health from a “buy” rating to a “hold” rating in a report on Saturday, July 8th. Zacks Investment Research downgraded LifePoint Health from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Piper Jaffray Companies reissued a “hold” rating and issued a $66.00 price target on shares of LifePoint Health in a report on Wednesday, October 4th. Finally, ValuEngine downgraded LifePoint Health from a “buy” rating to a “hold” rating in a report on Friday, September 1st. Three analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of $60.14.

LifePoint Health (NASDAQ:LPNT) last announced its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.60 billion. LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The company’s revenue for the quarter was down .7% on a year-over-year basis. During the same period last year, the business posted $0.94 EPS.

LifePoint Health declared that its Board of Directors has initiated a stock repurchase plan on Friday, October 27th that permits the company to buyback $200.00 million in outstanding shares. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.

TRADEMARK VIOLATION WARNING: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.americanbankingnews.com/2017/11/02/lifepoint-health-inc-lpnt-now-covered-by-credit-suisse-group-ag.html.

Several hedge funds have recently modified their holdings of LPNT. BlackRock Inc. increased its position in shares of LifePoint Health by 11,671.9% during the 1st quarter. BlackRock Inc. now owns 3,745,824 shares of the company’s stock valued at $245,351,000 after purchasing an additional 3,714,004 shares during the period. LSV Asset Management increased its position in shares of LifePoint Health by 83.5% during the 2nd quarter. LSV Asset Management now owns 1,994,557 shares of the company’s stock valued at $133,934,000 after purchasing an additional 907,469 shares during the period. Victory Capital Management Inc. increased its position in shares of LifePoint Health by 130.6% during the 2nd quarter. Victory Capital Management Inc. now owns 816,147 shares of the company’s stock valued at $54,804,000 after purchasing an additional 462,211 shares during the period. American Century Companies Inc. increased its position in shares of LifePoint Health by 7.7% during the 3rd quarter. American Century Companies Inc. now owns 3,630,487 shares of the company’s stock valued at $210,205,000 after purchasing an additional 260,944 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of LifePoint Health by 103.9% during the 1st quarter. Goldman Sachs Group Inc. now owns 408,284 shares of the company’s stock valued at $26,742,000 after purchasing an additional 208,084 shares during the period. Institutional investors own 99.53% of the company’s stock.

LifePoint Health Company Profile

LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.

Analyst Recommendations for LifePoint Health (NASDAQ:LPNT)

Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.